| 1 |
Mark S. Wilson |
Biomerieux |
4 |
| 1 |
Jay Copeland Strum |
G1 Therapeutics |
4 |
| 3 |
Kaitlin Emily Harrington |
Thermochem Recovery International |
3 |
| #4 |
Douglas Peters |
Adp |
2 |
| #4 |
Matthew J. Kostura |
Vtv Therapeutics |
2 |
| #4 |
Aaron Dominic Wyatt |
Engineered Controls International |
2 |
| #4 |
Lisa Ann Lyons |
Delta Five |
2 |
| #4 |
Wilson Christopher Lamb |
Rai Strategic Holdings |
2 |
| #4 |
Richard Raymond Shopmyer |
Adp |
2 |
| #4 |
Rickard E. Faith |
Netapp |
2 |
| #4 |
Scott P. Runyon |
Research Triangle Institute |
2 |
| #4 |
Boyd Yount |
University Of North Carolina At Chapel Hill |
2 |
| #4 |
Jennifer Greenwood Zawacki |
— |
2 |
| #14 |
Joseph Zuech |
Bell And Howell |
1 |
| #14 |
William J. Bulfin |
IBM |
1 |
| #14 |
Brian T. Irving |
Delta Electronics |
1 |
| #14 |
Bradley A. Bower |
Bioptigen |
1 |
| #14 |
Matthew Sadgrove |
University Of North Carolina At Chapel Hill |
1 |
| #14 |
Kurtis Keller |
Inneroptic Technology |
1 |
| #14 |
William S. Lynn |
Bach Pharma |
1 |
| #14 |
Paul J. Reder |
IBM |
1 |
| #14 |
Lori Artim Artim Mann |
— |
1 |
| #14 |
Duke Chang |
IBM |
1 |
| #14 |
Jeffrey P. Williams |
Parata Systems |
1 |
| #14 |
Marybeth Colleen Tetlow |
Duke University |
1 |
| #14 |
Steven L. Vanderlinden |
— |
1 |
| #14 |
William E. Atherton |
IBM |
1 |
| #14 |
Craig Capell |
Cree |
1 |
| #14 |
Thomas S. Wallace |
IBM |
1 |
| #14 |
Keith William Anderson |
— |
1 |
| #14 |
W. Andrew Grubbs |
Intuitive Surgical |
1 |
| #14 |
Virginia Byers Kraus |
— |
1 |
| #14 |
John Claassen Roberts |
Nitronex |
1 |
| #14 |
L. Mary Smith |
Gitr |
1 |
| #14 |
Marc G. Caron |
Duke University |
1 |
| #14 |
Robert Anthony Millet, Jr. |
— |
1 |
| #14 |
John Martin Jans |
Tearscience |
1 |
| #14 |
Dean Zehnder |
Amkor Technology |
1 |
| #14 |
James E. Ingold, Jr. |
Angiodynamics |
1 |